Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 1
1995 1
1998 2
1999 1
2001 2
2002 4
2003 4
2004 1
2005 3
2006 3
2008 1
2009 2
2010 2
2011 2
2013 6
2014 3
2015 2
2016 5
2017 4
2018 6
2019 3
2020 1
2021 9
2022 10
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Rhabdomyosarcoma.
Yechieli RL, Mandeville HC, Hiniker SM, Bernier-Chastagner V, McGovern S, Scarzello G, Wolden S, Cameron A, Breneman J, Fajardo RD, Donaldson SS. Yechieli RL, et al. Among authors: scarzello g. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28254. doi: 10.1002/pbc.28254. Pediatr Blood Cancer. 2021. PMID: 33818882 Review.
Primary vascular tumors of bone: A comprehensive literature review on classification, diagnosis and treatment.
Tortorelli I, Bellan E, Chiusole B, Murtas F, Ruggieri P, Pala E, Cerchiaro M, Buzzaccarini MS, Scarzello G, Krengli M, Bisinella G, Battisti S, Di Maggio A, Zagonel V, Tos APD, Sbaraglia M, Brunello A. Tortorelli I, et al. Among authors: scarzello g. Crit Rev Oncol Hematol. 2024 Mar;195:104268. doi: 10.1016/j.critrevonc.2024.104268. Epub 2024 Jan 17. Crit Rev Oncol Hematol. 2024. PMID: 38237880 Free article. Review.
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines.
Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C, Mandeville HC. Dávila Fajardo R, et al. Among authors: scarzello g. Radiother Oncol. 2024 Jun;195:110273. doi: 10.1016/j.radonc.2024.110273. Epub 2024 Apr 7. Radiother Oncol. 2024. PMID: 38588921 Free article.
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
De Salvo GL, Del Bianco P, Minard-Colin V, Chisholm J, Jenney M, Guillen G, Devalck C, Van Rijn R, Shipley J, Orbach D, Kelsey A, Rogers T, Guerin F, Scarzello G, Ferrari A, Cesen Mazic M, Merks JHM, Bisogno G; European Pediatric Soft Tissue Sarcoma Study Group. De Salvo GL, et al. Among authors: scarzello g. Cancer. 2024 Jul 1;130(13):2351-2360. doi: 10.1002/cncr.35258. Epub 2024 Feb 24. Cancer. 2024. PMID: 38400828 Free PMC article.
Long-term results from the multicentric European randomized phase 3 trial CWS/RMS-96 for localized high-risk soft tissue sarcoma in children, adolescents, and young adults.
Sparber-Sauer M, Ferrari A, Kosztyla D, Ladenstein R, Cecchetto G, Kazanowska B, Scarzello G, Ljungman G, Milano GM, Niggli F, Alaggio R, Vokuhl C, Casanova M, Klingebiel T, Zin A, Koscielniak E, Bisogno G. Sparber-Sauer M, et al. Among authors: scarzello g. Pediatr Blood Cancer. 2022 Sep;69(9):e29691. doi: 10.1002/pbc.29691. Epub 2022 Apr 19. Pediatr Blood Cancer. 2022. PMID: 35441463 Clinical Trial.
Primary intracranial fibrosarcoma.
Bisogno G, Roganovic J, Carli M, Scarzello G, Calderone M, Faggin R, Perilongo G. Bisogno G, et al. Among authors: scarzello g. Childs Nerv Syst. 2002 Nov;18(11):648-51. doi: 10.1007/s00381-002-0628-6. Epub 2002 Aug 15. Childs Nerv Syst. 2002. PMID: 12420128
Mitigating negative emotions through virtual reality and embodiment.
Sansoni M, Scarzello G, Serino S, Groff E, Riva G. Sansoni M, et al. Among authors: scarzello g. Front Hum Neurosci. 2022 Aug 3;16:916227. doi: 10.3389/fnhum.2022.916227. eCollection 2022. Front Hum Neurosci. 2022. PMID: 35992949 Free PMC article.
Management of vertebral radiotherapy dose in paediatric patients with cancer: consensus recommendations from the SIOPE radiotherapy working group.
Hoeben BA, Carrie C, Timmermann B, Mandeville HC, Gandola L, Dieckmann K, Ramos Albiac M, Magelssen H, Lassen-Ramshad Y, Ondrová B, Ajithkumar T, Alapetite C, Balgobind BV, Bolle S, Cameron AL, Davila Fajardo R, Dietzsch S, Dumont Lecomte D, van den Heuvel-Eibrink MM, Kortmann RD, Laprie A, Melchior P, Padovani L, Rombi B, Scarzello G, Schwarz R, Seiersen K, Seravalli E, Thorp N, Whitfield GA, Boterberg T, Janssens GO. Hoeben BA, et al. Among authors: scarzello g. Lancet Oncol. 2019 Mar;20(3):e155-e166. doi: 10.1016/S1470-2045(19)30034-8. Lancet Oncol. 2019. PMID: 30842059 Review.
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience.
Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC. Turcas A, et al. Among authors: scarzello g. Radiother Oncol. 2023 Oct;187:109810. doi: 10.1016/j.radonc.2023.109810. Epub 2023 Jul 17. Radiother Oncol. 2023. PMID: 37468069 Free article.
73 results